P. Izmirly

发表

A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self‐Administered Questionnaires

D. Isenberg, M. Petri, G. Baron, 2018, Clinical pharmacology and therapeutics.

High Systemic Type I Interferon Activity Is Associated With Active Class III/IV Lupus Nephritis

M. Jensen, S. Amin, J. Buyon, 2021, The Journal of Rheumatology.

Salivary dysbiosis and the clinical spectrum in anti-Ro positive mothers of children with neonatal lupus.

M. Blaser, C. Langefeld, M. Marion, 2020, Journal of autoimmunity.

Single cell RNA sequencing to dissect the molecular heterogeneity in lupus nephritis.

T. Tuschl, C. Putterman, Manjunath Kustagi, 2017, JCI insight.

Urine Proteomics and Renal Single‐Cell Transcriptomics Implicate Interleukin‐16 in Lupus Nephritis

N. Hacohen, S. Raychaudhuri, M. Petri, 2021, Arthritis & rheumatology.

Hydroxychloroquine to Prevent Recurrent Congenital Heart Block in Fetuses of Anti-SSA/Ro-Positive Mothers.

Mimi Y. Kim, B. Cuneo, D. Friedman, 2020, Journal of the American College of Cardiology.

Neonatal lupus: Clinical spectrum, biomarkers, pathogenesis, and approach to treatment

B. Cuneo, J. Buyon, P. Izmirly, 2021, Systemic Lupus Erythematosus.

Autoimmune-mediated congenital heart block.

J. Buyon, P. Izmirly, A. Saxena, 2020, Best practice & research. Clinical obstetrics & gynaecology.

Integrated urine proteomics and renal single-cell genomics identify an interferon-γ response gradient in lupus nephritis.

N. Hacohen, L. Magder, S. Raychaudhuri, 2020, JCI insight.

A protective Langerhans cell–keratinocyte axis that is dysfunctional in photosensitivity

C. Blobel, E. Pamer, P. Izmirly, 2018, Science Translational Medicine.

Incidence rates of systemic lupus erythematosus in the USA: estimates from a meta-analysis of the Centers for Disease Control and Prevention national lupus registries

C. Gordon, C. Helmick, P. Izmirly, 2021, Lupus Science & Medicine.

Epidemiology of lupus: an update

C. Gordon, C. Helmick, M. Dall'era, 2015, Current opinion in rheumatology.

Evaluation of SARS-CoV-2 IgG antibody reactivity in patients with systemic lupus erythematosus: analysis of a multi-racial and multi-ethnic cohort

Mimi Y. Kim, A. Troxel, A. Neimann, 2021, The Lancet Rheumatology.

European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) SLE classification criteria item performance

D. Gladman, J. Sánchez-Guerrero, M. Urowitz, 2021, Annals of the Rheumatic Diseases.

Safety of procuring research tissue during a clinically indicated kidney biopsy from patients with lupus: data from the Accelerating Medicines Partnership RA/SLE Network

K. Kalunian, M. Petri, D. Fine, 2021, Lupus Science & Medicine.

Autoimmune anti-DNA and anti-phosphatidylserine antibodies predict development of severe COVID-19

Kun Qian, J. Buyon, P. Izmirly, 2021, Life Science Alliance.

Autoantibody-mediated impairment of DNASE1L3 activity in sporadic systemic lupus erythematosus

Mimi Y. Kim, A. Tsirigos, Ali Rashidfarrokhi, 2021, The Journal of experimental medicine.

Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study

Mimi Y. Kim, J. Buyon, P. Izmirly, 2020, Arthritis Research & Therapy.

Performance of the 2019 EULAR/ACR classification criteria for systemic lupus erythematosus in early disease, across sexes and ethnicities

D. Gladman, J. Sánchez-Guerrero, M. Urowitz, 2020, Annals of the Rheumatic Diseases.

Systemic Autoimmune Disease Among Adults Exposed to the September 11, 2001 Terrorist Attack

Lysa J. Petrsoric, Sara A. Miller-Archie, P. Izmirly, 2019, Arthritis & rheumatology.

Validation of Systemic Lupus Erythematosus Diagnosis as the Primary Cause of Renal Failure in the US Renal Data System

P. Izmirly, W. Mowrey, K. Costenbader, 2017, Arthritis care & research.

Disease progression in mothers of children enrolled in the Research Registry for Neonatal Lupus

J. Buyon, P. Izmirly, J. Fischer, 2008, Annals of the rheumatic diseases.

Gut dysbiosis and the clinical spectrum in anti-Ro positive mothers of children with neonatal lupus

C. Langefeld, M. Marion, J. Buyon, 2022, Gut microbes.

Dysregulation of the Microvasculature in Nonlesional Non-Sun-exposed Skin of Patients with Lupus Nephritis

H. Yee, C. Esmon, J. Buyon, 2012, The Journal of Rheumatology.

Association of plasma soluble E-selectin and adiponectin with carotid plaque in patients with systemic lupus erythematosus.

Mimi Y. Kim, J. Buyon, P. Izmirly, 2010, Atherosclerosis.

Expression of endothelial protein C receptor in cortical peritubular capillaries associates with a poor clinical response in lupus nephritis.

Mimi Y. Kim, C. Esmon, J. Buyon, 2008, Rheumatology.

Use of Pharmacogenetics, Enzymatic Phenotyping, and Metabolite Monitoring to Guide Treatment with Azathioprine in Patients with Systemic Lupus Erythematosus

E. Seidman, M. Weisman, J. Buyon, 2008, The Journal of Rheumatology.

Rapid aneurysm growth and rupture in systemic lupus erythematosus

Paul P. Huang, P. Izmirly, T. Becske, 2015, Surgical neurology international.

Current Therapies for Lupus Nephritis in an Ethnically Heterogeneous Cohort

J. Buyon, P. Izmirly, H. Belmont, 2008, The Journal of Rheumatology.

Mortality in Systemic Lupus Erythematosus: an Updated Review

P. Izmirly, César E Fors Nieves, 2016, Current Rheumatology Reports.

Neonatal Lupus

D. Friedman, P. Izmirly, C. Phoon, 2019, Dubois' Lupus Erythematosus and Related Syndromes.

No histologic evidence of foetal cardiotoxicity following exposure to maternal hydroxychloroquine.

M. Halushka, D. Friedman, J. Buyon, 2017, Clinical and experimental rheumatology.

Prevention and Treatment In Utero of Autoimmune-Associated Congenital Heart Block

D. Friedman, J. Buyon, P. Izmirly, 2014, Cardiology in review.

Sex Differences in Systemic Lupus Erythematosus: Epidemiology, Clinical Considerations, and Disease Pathogenesis.

J. Buyon, P. Izmirly, M. Pillinger, 2020, Mayo Clinic proceedings.

Pregnancy outcomes in mixed connective tissue disease: a multicentre study.

J. Buyon, D. Roccatello, S. Sciascia, 2019, Rheumatology.

Passively acquired lupus in the fetus and neonate

J. Buyon, P. Izmirly, A. Saxena, 2021, Lahita's Systemic Lupus Erythematosus.

Early diagnosis of primary Sjögren’s syndrome: EULAR-SS task force clinical recommendations

X. Mariette, E. Theander, S. Bombardieri, 2016, Expert review of clinical immunology.

TWEAK/Fn14 Signaling Involvement in the Pathogenesis of Cutaneous Disease in the MRL/lpr Model of Spontaneous Lupus

C. Putterman, L. Burkly, P. Izmirly, 2015, The Journal of investigative dermatology.

Erythrocyte complement receptor 1 (ECR1) and erythrocyte-bound C4d (EC4d) in the prediction of poor pregnancy outcomes in systemic lupus erythematosus (SLE)

J. Conklin, J. Buyon, P. Izmirly, 2022, Lupus Science & Medicine.

Discontinuation of hydroxychloroquine in older patients with systemic lupus erythematosus: a multicenter retrospective study

Mimi Y. Kim, J. Buyon, P. Izmirly, 2020, Arthritis Research & Therapy.

OP0020 Validation of new systemic lupus erythematosus classification criteria

M. Urowitz, X. Mariette, M. Aringer, 2018, WEDNESDAY, 13 JUNE 2018.

Breakthrough SARS-CoV-2 infections, morbidity, and seroreactivity following initial COVID-19 vaccination series and additional dose in patients with SLE in New York City

J. Buyon, P. Izmirly, J. Scher, 2022, The Lancet Rheumatology.

Methotrexate combined with isoniazid treatment for latent tuberculosis is well tolerated in patients with rheumatoid arthritis: experience from an urban arthritis clinic

J. Greenberg, P. Izmirly, M. Kishimoto, 2007, Annals of the rheumatic diseases.

Electrocardiographic QT Intervals in Infants Exposed to Hydroxychloroquine Throughout Gestation

Mimi Y. Kim, B. Cuneo, D. Friedman, 2020, Circulation. Arrhythmia and electrophysiology.

Covid-19 in Immune-Mediated Inflammatory Diseases — Case Series from New York

A. Neimann, P. Izmirly, J. Scher, 2020, The New England journal of medicine.

Assessment of fluorinated steroids to avert progression and mortality in anti-SSA/Ro-associated cardiac injury limited to the fetal conduction system

Mimi Y. Kim, D. Friedman, J. Buyon, 2015, Annals of the rheumatic diseases.

Neonatal lupus: Clinical spectrum, biomarkers, pathogenesis, and approach to treatment

B. Cuneo, J. Buyon, P. Izmirly, 2016 .

Block-Enolase in Mothers of Children with Congenital Heart α Antibody Reactivity to

J. Buyon, E. Chan, P. Izmirly, 2009 .

Preclinical Carotid Atherosclerosis in Patients With Rheumatoid ArthritisRoman MJ, Moeller E, Davis A, et al (Cornell Univ, New York; Rogosin Inst, New York; SUNY–Stony Brook, NY) Ann Intern Med 144:249–256, 2006§

P. Izmirly, 2006 .

Serum Biomarkers of Inflammation, Fibrosis, and Cardiac Function in Facilitating Diagnosis, Prognosis, and Treatment of Anti-SSA/Ro-Associated Cardiac Neonatal Lupus.

S. W. Han, D. Friedman, J. Buyon, 2015, Journal of the American College of Cardiology.

Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease

M. Neurath, S. Abramson, M. Mulligan, 2021, Annals of the Rheumatic Diseases.

Evaluation of Fetuses in the Preventive IVIG Therapy for Congenital Heart Block (PITCH) study

Mimi Y. Kim, D. Friedman, J. Buyon, 2011 .

Lupus disease flares are concordant with immune responses to blooms of lipoglycan-expressing Ruminococcus blautia gnavus strains arising from unstable gut microbiota communities

A. Heguy, A. Alekseyenko, D. Schwudke, 2022, bioRxiv.

Neonatal lupus: advances in understanding pathogenesis and identifying treatments of cardiac disease.

J. Buyon, P. Izmirly, A. Saxena, 2012, Current opinion in rheumatology.

Neonatal lupus: advances in understanding pathogenesis and identifying treatments of cardiac disease

J. Buyon, P. Izmirly, A. Saxena, 2012, Current opinion in rheumatology.

2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

D. Gladman, J. Sánchez-Guerrero, M. Urowitz, 2019, Arthritis & rheumatology.

Cutaneous manifestations of neonatal lupus and risk of subsequent congenital heart block.

Mimi Y. Kim, J. Buyon, P. Izmirly, 2010, Arthritis and rheumatism.

Effect of in utero hydroxychloroquine exposure on the development of cutaneous neonatal lupus erythematosus

J. Buyon, E. Silverman, N. Costedoat-Chalumeau, 2018, Annals of the rheumatic diseases.

Recurrence rates of cardiac manifestations associated with neonatal lupus and maternal/fetal risk factors.

Mimi Y. Kim, D. Friedman, J. Buyon, 2009, Arthritis and rheumatism.

Umbilical cord blood levels of maternal antibodies reactive with p200 and full‐length Ro 52 in the assessment of risk for cardiac manifestations of neonatal lupus

J. Buyon, P. Izmirly, R. Clancy, 2012, Arthritis care & research.

The immune cell landscape in kidneys of patients with lupus nephritis

Nir Hacohen, Matthias Kretzler, Kamil Slowikowski, 2019, Nature Immunology.

Accelerating Medicines Partnership: Organizational Structure and Preliminary Data From the Phase 1 Studies of Lupus Nephritis

Paul J. Hoover, N. Hacohen, M. Petri, 2020, Arthritis care & research.

Tubular Cell and Keratinocyte Single-cell Transcriptomics Applied to Lupus Nephritis Reveal Type I IFN and Fibrosis Relevant Pathways

Kamil Slowikowski, Soumya Raychaudhuri, Manjunath Kustagi, 2019, Nature Immunology.

2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus

D. Gladman, J. Sánchez-Guerrero, M. Urowitz, 2019, Annals of the rheumatic diseases.

SLE: reconciling heterogeneity

J. Buyon, P. Izmirly, M. Barbhaiya, 2019, Lupus Science & Medicine.

Evaluation of fetuses in a study of intravenous immunoglobulin as preventive therapy for congenital heart block: Results of a multicenter, prospective, open-label clinical trial.

Mimi Y Kim, Philip Samuels, Mimi Y. Kim, 2010, Arthritis and rheumatism.

Anatomical and pathological findings in hearts from fetuses and infants with cardiac manifestations of neonatal lupus.

M. Halushka, D. Friedman, J. Buyon, 2012, Rheumatology.

Evaluation of the risk of anti-SSA/Ro-SSB/La antibody-associated cardiac manifestations of neonatal lupus in fetuses of mothers with systemic lupus erythematosus exposed to hydroxychloroquine

Mimi Y. Kim, J. Buyon, P. Izmirly, 2010, Annals of the rheumatic diseases.

The clinical spectrum of autoimmune congenital heart block

J. Buyon, M. Khamashta, P. Izmirly, 2015, Nature Reviews Rheumatology.

Maternal Use of Hydroxychloroquine Is Associated With a Reduced Risk of Recurrent Anti-SSA/Ro-Antibody–Associated Cardiac Manifestations of Neonatal Lupus

Mimi Y. Kim, J. Piette, D. Friedman, 2012, Circulation.

Maternal and Fetal Factors Associated With Mortality and Morbidity in a Multi–Racial/Ethnic Registry of Anti-SSA/Ro–Associated Cardiac Neonatal Lupus

Mimi Y. Kim, D. Friedman, J. Buyon, 2011, Circulation.

Tubulointerstitial damage predicts end stage renal disease in lupus nephritis with preserved to moderately impaired renal function: A retrospective cohort study.

C. Putterman, P. Izmirly, W. Mowrey, 2018, Seminars in arthritis and rheumatism.

COVID‐19 in Patients With Inflammatory Arthritis: A Prospective Study on the Effects of Comorbidities and Disease‐Modifying Antirheumatic Drugs on Clinical Outcomes

A. Ogdie, A. Troxel, P. Izmirly, 2020, Arthritis & rheumatology.

Leveraging the United States Epicenter to Provide Insights on COVID‐19 in Patients With Systemic Lupus Erythematosus

Mimi Y. Kim, J. Buyon, P. Izmirly, 2020, Arthritis & rheumatology.

Methotrexate hampers immunogenicity to BNT162b2 mRNA COVID-19 vaccine in immune-mediated inflammatory disease

M. Neurath, S. Abramson, M. Mulligan, 2021, Annals of the Rheumatic Diseases.

Evaluation of Immune Response and Disease Status in Systemic Lupus Erythematosus Patients Following SARS–CoV‐2 Vaccination

Mimi Y. Kim, M. Mulligan, J. Buyon, 2021, Arthritis & rheumatology.

The Pretreatment Gut Microbiome Is Associated With Lack of Response to Methotrexate in New‐Onset Rheumatoid Arthritis

P. Turnbaugh, S. Abramson, C. Ubeda, 2020, Arthritis & rheumatology.

Factors associated with long-term cardiac dysfunction in neonatal lupus

Mimi Y. Kim, D. Friedman, J. Buyon, 2019, Annals of the rheumatic diseases.

Clinical and pathologic implications of extending the spectrum of maternal autoantibodies reactive with ribonucleoproteins associated with cutaneous and now cardiac neonatal lupus from SSA/Ro and SSB/La to U1RNP.

M. Halushka, J. Buyon, P. Izmirly, 2017, Autoimmunity reviews.

The Incidence and Prevalence of Systemic Lupus Erythematosus in New York County (Manhattan), New York: The Manhattan Lupus Surveillance Program

C. Gordon, C. Helmick, C. Putterman, 2017, Arthritis & rheumatology.

The NYU Children’s Health and Environment Study

L. Trasande, D. Fenyo, J. Buyon, 2020, European Journal of Epidemiology.

A Prospective International Study on Adherence to Treatment in 305 Patients With Flaring SLE: Assessment by Drug Levels and Self‐Administered Questionnaires

D. Isenberg, M. Petri, G. Baron, 2018, Clinical pharmacology and therapeutics.

The Incidence and Prevalence of Adult Primary Sjögren's Syndrome in New York County

C. Gordon, C. Helmick, C. Putterman, 2019, Arthritis care & research.

Insights from Comparison of the Renal and Skin Single Cell Transcriptomes in Lupus Nephritis

S. Raychaudhuri, T. Tuschl, C. Putterman, 2018, bioRxiv.

Methotrexate and TNF inhibitors affect long-term immunogenicity to COVID-19 vaccination in patients with immune-mediated inflammatory disease

M. Mulligan, A. Neimann, P. Izmirly, 2022, The Lancet Rheumatology.

Progress in the pathogenesis and treatment of cardiac manifestations of neonatal lupus

J. Buyon, P. Izmirly, A. Saxena, 2017, Current opinion in rheumatology.

In search of an antibody specificity highly predictive of congenital heart block

P. Izmirly, A. Saxena, 2016, Lupus Science & Medicine.

Autoimmune Congenital Complete Heart Block: How Late Can It Occur?

J. Buyon, P. Izmirly, C. Phoon, 2022, American Journal of Perinatology Reports.

Antibody Reactivity to α-Enolase in Mothers of Children with Congenital Heart Block

J. Buyon, E. Chan, P. Izmirly, 2009, The Journal of Rheumatology.

SLE clinical trials: impact of missing data on estimating treatment effects

Mimi Y. Kim, K. Kalunian, P. Izmirly, 2019, Lupus Science & Medicine.

Modeling of clinical phenotypes in systemic lupus erythematosus based on the platelet transcriptome and FCGR2a genotype

Kelly V. Ruggles, J. Buyon, K. Ruggles, 2023, Journal of Translational Medicine.

Platelet LGALS3BP as a Mediator of Myeloid Inflammation in Systemic Lupus Erythematosus

Kelly V. Ruggles, J. Berger, J. Buyon, 2022, Arthritis & rheumatology.

Evaluation of the EULAR/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus in a Population‐Based Registry

C. Gordon, C. Helmick, C. Putterman, 2022, Arthritis care & research.

Population-based prevalence and incidence estimates of primary discoid lupus erythematosus from the Manhattan Lupus Surveillance Program

C. Gordon, C. Helmick, C. Putterman, 2019, Lupus Science & Medicine.

Evaluating duration of response to treatment in systemic lupus erythematosus clinical trials

Mimi Y. Kim, K. Kalunian, P. Izmirly, 2018, Lupus Science & Medicine.

Brief Report: Longitudinal Patterns of Response to Standard of Care Therapy for Systemic Lupus Erythematosus: Implications for Clinical Trial Design

Mimi Y. Kim, K. Kalunian, P. Izmirly, 2017, Arthritis & rheumatology.

Role of hypoxia and cAMP in the transdifferentiation of human fetal cardiac fibroblasts: implications for progression to scarring in autoimmune-associated congenital heart block.

J. Zavadil, J. Buyon, P. Izmirly, 2007, Arthritis and rheumatism.

Longitudinal gut microbiome analyses and blooms of pathogenic strains during lupus disease flares

A. Heguy, A. Alekseyenko, D. Schwudke, 2023, Annals of the Rheumatic Diseases.

Correction: Population-based prevalence and incidence estimates of primary discoid lupus erythematosus from the Manhattan Lupus Surveillance Program

C. Gordon, C. Helmick, C. Putterman, 2019, Lupus Science & Medicine.

Molnupiravir and Nirmatelvir/Ritonavir in the Treatment of Patients With Systemic Autoimmune Rheumatic Disease With SARS-CoV-2

P. Izmirly, K. Corbitt, Amit Saxena, 2023, The Journal of Rheumatology.

Urine proteomic signatures of histological class, activity, chronicity, and treatment response in lupus nephritis

Goldman, N. Hacohen, L. Magder, 2023, medRxiv.

Hydroxychloroquine is associated with lower platelet activity and improved vascular health in systemic lupus erythematosus

Kelly V. Ruggles, J. Berger, J. Buyon, 2021, Lupus Science & Medicine.

Neonatal lupus syndromes

J. Buyon, P. Izmirly, R. Clancy, 2004, Rheumatic diseases clinics of North America.

Intrarenal myeloid subsets associated with kidney injury are comparable in mice and patients with lupus nephritis

Linda T. Nieman, Joyce B. Kang, N. Hacohen, 2023, bioRxiv.

Autoimmune congenital heart block: complex and unusual situations

J. Buyon, M. Khamashta, P. Izmirly, 2016, Lupus.

Neonatal lupus syndromes.

J. Buyon, P. Izmirly, C. Tseng, 1997, Rheumatic diseases clinics of North America.

Knowledge is power: regarding SMFM Consult Series #64: Systemic lupus erythematosus in pregnancy.

J. Rychik, M. Donofrio, M. Sklansky, 2023, American journal of obstetrics and gynecology.

Resolution of large aortic valve vegetations in antiphospholipid syndrome treated with therapeutic anticoagulation: a report of two cases and literature review

P. Izmirly, E. Yuriditsky, H. Belmont, 2018, Lupus.

Author Correction: Tubular cell and keratinocyte single-cell transcriptomics applied to lupus nephritis reveal type I IFN and fibrosis relevant pathways

N. Hacohen, S. Raychaudhuri, T. Tuschl, 2019, Nature Immunology.

Integration of urine proteomics and renal single-cell genomics identifies an interferon-gamma response gradient in lupus nephritis.

N. Hacohen, L. Magder, S. Raychaudhuri, 2020, medRxiv.

Prevalence of Systemic Lupus Erythematosus in the United States: Estimates From a Meta‐Analysis of the Centers for Disease Control and Prevention National Lupus Registries

P. Izmirly, M. Dall'Era, E. Ferucci, 2021, Arthritis & rheumatology.

Maternal and Fetal Factors Associated With Mortality and Morbidity in a Multi–Racial/Ethnic Registry of Anti-SSA/Ro–Associated Cardiac Neonatal Lupus

Mimi Y. Kim, D. Friedman, J. Buyon, 2011, Circulation.

Frequency of neuro-psychiatric dysfunction in anti-SSA/SSB exposed children with and without neonatal lupus

P. Izmirly, J. Mumtaz, A. Askanase, 2010, Lupus.

Early diagnosis of primary Sjögren’s syndrome: EULAR-SS task force clinical recommendations

X. Mariette, E. Theander, S. Bombardieri, 2016, Expert review of clinical immunology.

Neonatal Lupus

D. Friedman, P. Izmirly, C. Phoon, 2019, Dubois' Lupus Erythematosus and Related Syndromes.

Serum Biomarkers of Inflammation, Fibrosis, and Cardiac Function in Facilitating Diagnosis, Prognosis, and Treatment of Anti-SSA/Ro-Associated Cardiac Neonatal Lupus.

S. W. Han, D. Friedman, J. Buyon, 2015, Journal of the American College of Cardiology.

Inhibiting the P2Y12 Receptor in Megakaryocytes and Platelets Suppresses Interferon-Associated Responses

P. Izmirly, Tessa J. Barrett, Florencia Schlamp, 2024, JACC: Basic to Translational Science.

Osteonecrosis is associated with APOL1 variants in African Americans with systemic lupus erythematosus

P. Izmirly, Ashira Blazer, Huda Algasas, 2023, Frontiers in Lupus.

Clinical and Serologic Phenotyping and Damage Indices in Patients With Systemic Lupus Erythematosus With and Without Fibromyalgia

P. Izmirly, M. Masson, P. Carlucci, 2024, ACR open rheumatology.

High incidence of proliferative and membranous nephritis in SLE patients with low proteinuria in the Accelerating Medicines Partnership.

K. Kalunian, M. Petri, D. Fine, 2022, Rheumatology.

Prevalence of cardiovascular events in a population-based registry of patients with systemic lupus erythematosus

P. Izmirly, E. Ginzler, A. Askanase, 2024, Arthritis research & therapy.